921![Division: Pharmacy Services Subject: Prior Authorization Criteria – Abilify Maintena Original Development Date: Original Effective Date: Division: Pharmacy Services Subject: Prior Authorization Criteria – Abilify Maintena Original Development Date: Original Effective Date:](https://www.pdfsearch.io/img/f2cdcbf6a56814b31f295bd61dfb9d8f.jpg) | Add to Reading ListSource URL: ahca.myflorida.comLanguage: English - Date: 2013-10-16 14:46:59
|
---|
922![The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid 600 Washington Street Boston, MA[removed]DEVAL L. PATRICK The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid 600 Washington Street Boston, MA[removed]DEVAL L. PATRICK](https://www.pdfsearch.io/img/a0cbe7037e9f155296fbf025cf9e41f5.jpg) | Add to Reading ListSource URL: www.mass.govLanguage: English - Date: 2014-09-09 13:08:39
|
---|
923![Pediatric Phase I / Pilot Consortium Malcolm A. Smith, MD, PhD Cancer Therapy Evaluation Program November 2011
Pediatric Phase I / Pilot Consortium – Pediatric Phase I / Pilot Consortium Malcolm A. Smith, MD, PhD Cancer Therapy Evaluation Program November 2011
Pediatric Phase I / Pilot Consortium –](https://www.pdfsearch.io/img/d8b154aa513ee825a097de2eec665c38.jpg) | Add to Reading ListSource URL: deainfo.nci.nih.govLanguage: English - Date: 2011-11-14 10:42:10
|
---|
924![NCL Calculations Dec 2008.xlsx NCL Calculations Dec 2008.xlsx](https://www.pdfsearch.io/img/c7ace55ab7009956f03bc9d5f24fdf18.jpg) | Add to Reading ListSource URL: ndep.nv.govLanguage: English - Date: 2008-12-18 14:48:54
|
---|
925![[removed]Federal Register / Vol. 69, No[removed]Wednesday, August 4, [removed]Notices agency withdraws or suspends approval of the drug’s NDA or ANDA for reasons [removed]Federal Register / Vol. 69, No[removed]Wednesday, August 4, [removed]Notices agency withdraws or suspends approval of the drug’s NDA or ANDA for reasons](https://www.pdfsearch.io/img/e692f27e27faaa09c10c3ab386d311ed.jpg) | Add to Reading ListSource URL: archive.hhs.govLanguage: English - Date: 2004-08-06 13:09:06
|
---|
926![Health / Ciprofloxacin / Pefloxacin / Quinolone / Enrofloxacin / Ofloxacin / Bayer / Antibiotic resistance / Norfloxacin / Piperazines / Medicine / Chemistry Health / Ciprofloxacin / Pefloxacin / Quinolone / Enrofloxacin / Ofloxacin / Bayer / Antibiotic resistance / Norfloxacin / Piperazines / Medicine / Chemistry](/pdf-icon.png) | Add to Reading ListSource URL: phsj.orgLanguage: English - Date: 2009-05-19 13:46:36
|
---|
927![Neuroleptic Drugs and Violence Neuroleptic Drugs and Violence](https://www.pdfsearch.io/img/548a1f41bdfede54b78830b6ec76dccd.jpg) | Add to Reading ListSource URL: psychrights.orgLanguage: English - Date: 2013-01-10 14:44:54
|
---|
928![Division of Anti-Infective and Ophthalmology Products (DAIOP) Briefing Document Joint Meeting of the Anti-Infective Drug Advisory Committee and Division of Anti-Infective and Ophthalmology Products (DAIOP) Briefing Document Joint Meeting of the Anti-Infective Drug Advisory Committee and](https://www.pdfsearch.io/img/9d11bb7730b4fe18a5ea5932d4316d4f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2006-12-13 08:08:06
|
---|
929![PRODUCT MONOGRAPH JEVTANA® Pr PRODUCT MONOGRAPH JEVTANA® Pr](https://www.pdfsearch.io/img/a84c161f1efab40b21a44dbc56ced324.jpg) | Add to Reading ListSource URL: products.sanofi.caLanguage: English - Date: 2014-04-30 09:06:40
|
---|
930![PLoS MEDICINE A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial) Clive Ballard1*, Marisa Margallo Lana2, Megan Theodoulou3, Simon Douglas4, Ruper PLoS MEDICINE A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial) Clive Ballard1*, Marisa Margallo Lana2, Megan Theodoulou3, Simon Douglas4, Ruper](https://www.pdfsearch.io/img/1f9a60ff1cec2e12364d0a60fd0ec357.jpg) | Add to Reading ListSource URL: psychrights.orgLanguage: English - Date: 2008-04-02 12:12:28
|
---|